Compound 1738
Identifiers
- Canonical SMILES:
OC(C1CCN(CCCOc2ccc(cc2)C#N)CC1)(c1ccccc1)c1ccccc1
- IUPAC name:
4-{3-[4-(hydroxydiphenylmethyl)piperidin-1-yl]propoxy}benzonitrile
- InChi:
InChI=1S/C28H30N2O2/c29-22-23-12-14-27(15-13-23)32-21-7-18-30-19-16-26(17-20-30)28(31,24-8-3-1-4-9-24)25-10-5-2-6-11-25/h1-6,8-15,26,31H,7,16-21H2
- InChiKey:
PFDYBDSSCPZQSF-UHFFFAOYSA-N
External links
![]() 44543700 |
![]() CHEMBL3126202 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MENIN / MLL | 4.97 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 426.23 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 4.82 | |||
TPSA | 56.49 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6750 | Diphenidol | DB01231 | |
0.6585 | Terfenadine | DB00342 | |
0.6145 | Pridinol | DB13642 | |
0.6136 | Quifenadine | DB13713 | |
0.6044 | Nisoxetine | DB09186 | |
0.5957 | (R)-Fluoxetine | DB08472 | |
0.5957 | (S)-Fluoxetine | DB08544 | |
0.5957 | Fluoxetine | DB00472 | |
0.5870 | Atomoxetine | DB00289 | |
0.5870 | Fexofenadine | DB00950 | |
0.5806 | Seproxetine | DB06731 | |
0.5773 | Dyclonine | DB00645 | |
0.5714 | Ifenprodil | DB08954 | |
0.5670 | Tramadol | DB00193 | |
0.5625 | Umeclidinium | DB09076 |